Successful long-term treatment of hepatic carnitine palmitoyltransferase I deficiency and a novel mutation.
Article Details
- CitationCopy to clipboard
Stoler JM, Sabry MA, Hanley C, Hoppel CL, Shih VE
Successful long-term treatment of hepatic carnitine palmitoyltransferase I deficiency and a novel mutation.
J Inherit Metab Dis. 2004;27(5):679-84.
- PubMed ID
- 15669684 [ View in PubMed]
- Abstract
Individuals with carnitine palmitoyltransferase I (CPT-I) deficiency cannot metabolize long-chain fatty acids and can develop life-threatening hypoglycaemia. We present a boy with CPT-I deficiency maintained on a very low-fat diet with nighttime uncooked cornstarch feedings for 5(1/2) years with good success. He has had normal growth and no episodes of hypoglycaemia or adverse side-effects. We found that he was homozygous for a previously undescribed mutation, T314I, in the CPT1A protein.